CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 150 filers reported holding CARA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $47,096,000 | +17.1% | 2,169,351 | -18.4% | 0.20% | +5.7% |
Q4 2020 | $40,212,000 | +48.8% | 2,657,796 | +25.1% | 0.19% | +38.1% |
Q3 2020 | $27,033,000 | -17.3% | 2,124,421 | +11.2% | 0.14% | -26.5% |
Q2 2020 | $32,675,000 | +71.5% | 1,910,821 | +32.5% | 0.19% | +53.7% |
Q1 2020 | $19,054,000 | -18.0% | 1,442,421 | 0.0% | 0.12% | +5.1% |
Q4 2019 | $23,237,000 | -31.9% | 1,442,421 | -22.7% | 0.12% | -37.8% |
Q3 2019 | $34,113,000 | -18.1% | 1,866,188 | -3.7% | 0.19% | -18.6% |
Q2 2019 | $41,671,000 | +116.5% | 1,938,188 | +97.5% | 0.23% | +108.1% |
Q1 2019 | $19,251,000 | +77.0% | 981,220 | +17.3% | 0.11% | +63.2% |
Q4 2018 | $10,876,000 | -18.5% | 836,642 | +50.2% | 0.07% | -4.2% |
Q3 2018 | $13,340,000 | +25.1% | 557,000 | 0.0% | 0.07% | +16.4% |
Q2 2018 | $10,666,000 | +373.2% | 557,000 | +205.9% | 0.06% | +369.2% |
Q1 2018 | $2,254,000 | +80.6% | 182,100 | +78.5% | 0.01% | +85.7% |
Q4 2017 | $1,248,000 | – | 102,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |